NCT04764370

Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Hangzhou Endonom Medtech Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This study is the first in man study of WeFlow-Arch Module Embedded Aorta Arch Stent Graft System

Detailed description

The WeFlow-Arch Moduler Embedded Aorta Arch Stent Graft System first in man study is a prospective, single center, single arm trial, which will enroll a total of 20 patients. The goal of this study is to evaluate the safety and efficacy of WeFlow-Arch Moduler Embedded Aorta Arch Stent Graft System in the treatment of patients with lesions of the aortic arch.

Conditions

• Aortic Arch; Aneurysm, Dissecting

Interventions

Type	Name	Description
DEVICE	WeFlow-Ach Moduler Embedded Branch Stent Graft System	The modular embedded aortic arch stent graft system consists of the embedded ascending aorta stent graft system, the arch aorta stent graft system and the branch stent system.

Timeline

• Start date: 2019-02-28
• Primary completion: 2022-10-22
• Completion: 2022-10-22
• First posted: 2021-02-21
• Last updated: 2024-04-30

Locations

1 site across 1 country: China